NCT05449457

Brief Summary

Following skin surgeries on the head and neck, several surgeons use a type of surgical glue (such as Dermabond) as a final layer on the top of wound. This glue is thought to seal the wound. Up until this point, there is limited data about the exact advantages or disadvantages of using this glue. We wish to determine if there is a difference in the cosmetic outcome of the scar when the glue is applied compared to when the glue is not applied. In addition, we want to determine if patients prefer to care for a wound with or without the glue.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 5, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 8, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

October 6, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 9, 2023

Completed
Last Updated

June 14, 2024

Status Verified

June 1, 2023

Enrollment Period

8 months

First QC Date

July 5, 2022

Last Update Submit

June 12, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS)

    The primary endpoint will be the score of two blinded reviewers independently using the POSAS assessment. The observer scale of the POSAS consists of six items (vascularity, pigmentation, thickness, relief, pliability, and surface area). All items are scored on a scale ranging from 1 ("like normal skin") to 10 ("worst scar imaginable"). The sum of the six items results in a total score of the POSAS observer scale. Furthermore, an overall opinion is scored on a scale ranging from 1 to 10. All parameters should preferably be compared to normal skin on a comparable anatomic location.

    3 months

  • Width of Scar as measured using Trace-to-Tape Method

    The trace-to-tape method is an objective measure for linear postoperative scars. The mean scar width will be determined using the trace-to-tape method. The surface area of the scar will be collected by tracing the scar with a water-based gel pen. While still wet, the gel residue will be lifted from the skin with clear packing tape and transferred on a sheet of paper.

    3 months

Secondary Outcomes (1)

  • Complications or Adverse Events from Treatment

    3 months

Study Arms (2)

Layered Closure

NO INTERVENTION

One half of the wound will have a cutaneous layer of sutures (2 layers), as is standard of care, while the other half of the wound will have an additional layer of 2-octyl cyanoacrylate (3 layers).

Layered Closure with 2-Octyl Cyanoacrylate

EXPERIMENTAL

One half of the wound will have a cutaneous layer of sutures (2 layers), as is standard of care, while the other half of the wound will have an additional layer of 2-octyl cyanoacrylate (3 layers).

Other: 2-Octyl cyanoacrylate

Interventions

Involves closure supplemented by 2-octyl cyanoacrylate (3 layers)

Also known as: Dermabond
Layered Closure with 2-Octyl Cyanoacrylate

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Able to give informed consent themselves
  • Patient scheduled for cutaneous surgical procedure on the face or neck with predicted primary closure.
  • Willing to return for follow up visit

You may not qualify if:

  • Incarceration
  • Under 18 years of age
  • Pregnant women
  • Unable to understand written and oral English.
  • Wounds with predicted closure length less than 3 cm
  • None of these special populations will be included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Davis - Dermatology Department

Sacramento, California, 95816, United States

Location

MeSH Terms

Conditions

Cicatrix

Interventions

octyl 2-cyanoacrylate

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Daniel Eisen, MD

    University of California, Davis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Two blinded observers will record their scores independently using the POSAS instrument.
Purpose
OTHER
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2022

First Posted

July 8, 2022

Study Start

October 6, 2022

Primary Completion

June 9, 2023

Study Completion

June 9, 2023

Last Updated

June 14, 2024

Record last verified: 2023-06

Locations